FTMIG LIVE from Midas Letter Studio (Full Video) – January 30, 2019 скачать в хорошем качестве

FTMIG LIVE from Midas Letter Studio (Full Video) – January 30, 2019

MediPharm Labs CEO, Pat McCutcheon! A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products. MediPharm Labs is also a Canadian Cannabis Awards Winner! TSX-V:LABS OTC:MLCPF Relevium Technologies Inc. Director & CEO, Aurelio Useche! Relevium is strategically focused on the expansion and acquisition of entrepreneurial brands within the health and wellness sector! Brands in their company Focus on Nutraceutical and Pharmaceutical of cannabinoid infused formulations for pediatric and adult medical applications with Biocannabix as well as BioGanix which is a cutting-edge line of weight-loss, health, beauty improvement and fitness supplements and products! TSX-V:RLV OTC:RLLVF Chris Arthur CIM CFP CLU, answers your requested questions in FTMIG’s “Ask a Fund Manager”! Technical Analysis Guru, Jonny Mac, covers the charts you requested! $GGI $JUJU $TGOD We talk trending topics -We interact with our live audience throughout the show! LIVE STREAM of our show will be available on our FTMIG page at the following link:   / ftminvest   TUNE IN every Wednesday from 1-3pm EST on Midas Letter (midasletter.com) where we bring you the most current interviews, special guests, T.A., and discussions on the most interesting companies in the hottest sectors. Join our FREE membership for access to EXCLUSIVE early-round investment opportunities! ** https://www.ftmig.com/membership Built by investors, for investors. Be in the know and FOLLOW THE MONEY! FULL VIDEOS will also be available on our website at www.ftmig.com and don’t forget to Like, follow, and share our FTMIG LIVE page, YouTube, and Twitter for all our exclusive videos and updates!!   / ftminvestment      / ftmmedia     / ftminvest